SMid Cap Biotech Analyst Joseph holds a conference call with CEO Butler on February 28 at 1 pm hosted by JPMorgan. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BMEA:
- Biomea Fusion participates in a conference call with JPMorgan
- Biomea Fusion initiated with a Buy at Citi
- Biomea Fusion doses first patient in COVALENT-102 trial of BMF-219
- Biomea Fusion highlights 2023 corporate milestones
- Biomea Fusion Announces Dosing of First Patient with Type 2 Diabetes in the United States in Ongoing Phase I/II (COVALENT-111) Study of BMF-219